Table 3.
Multinomial logistic regression analysis of sHLA-G between COVID-19 patients and controls.
| Model | Analysis | Serum level of sHLA-G; ng/mL |
|||
|---|---|---|---|---|---|
| Quartile 1 (<25%) | Quartile 2 (25–50%) | Quartile 3 (>50–75%) | Quartile 4 (>75%) | ||
| I | OR (95% CI) | Reference | 1.75 (0.66–4.66) | 12.09 (4.64–31.50) | 41.21 (13.22–128.49) |
| p-value | 0.265 | <0.001 | <0.001 | ||
| II | OR (95% CI) | Reference | 1.46 (0.40–5.30) | 8.88 (2.51–31.40) | 26.78 (6.53–109.79) |
| p-value | 0.562 | 0.001 | <0.001 | ||
| III | OR (95% CI) | Reference | 1.47 (0.41–5.29) | 9.04 (2.58–31.72) | 29.39 (7.05–122.58) |
| p-value | 0.552 | 0.001 | <0.001 | ||
| IV | OR (95% CI) | Reference | 1.73 (0.47–6.34) | 11.56 (3.15–42.37) | 43.34 (9.63–195.12) |
| p-value | 0.401 | <0.001 | <0.001 | ||
Model I: Unadjusted analysis; Model II: Adjusted for age; Model III: Adjusted for age and gender; Model IV: Adjusted for age, gender and body mass index; OR: Odds ratio; CI: Confidence interval; p: Probability (significant p-value is indicated in bold).